Episode 4: Eosinophilic Esophagitis and Celiac Disease. What Can I Eat? (32 min.)

$0.00

<< Return to Courses

In this episode, Dr. Erin Syverson describes the relationship between celiac disease and eosinophilic esophagitis. Furthermore, Dr. Syverson identifies indicators to test a patient with celiac disease for eosinophilic esophagitis. Dr. Syverson and Tara McCarthy, MS, RD, LDN also explain the nutritional challenges for patients with a dual diagnosis of celiac disease and eosinophilic esophagitis.

Category:

Description

Vanessa Weisbrod headshotVanessa Weisbrod
Director, Celiac Disease Program

 

 

 

 

Janis Arnold headshot

Janis Arnold, MSW, LICSW

Clinical Social Worker, Division of Gastroenterology, Hepatology, and Nutrition

 

 

 

Erin Syverson headshotErin Syverson, MD

Associate Director, Eosinophilic Gastrointestinal Disease Program;
Attending Physician, Division of Gastroenterology, Hepatology, and Nutrition

Instructor of Pediatrics, Harvard Medical School

 

Tara McCarthy headshot

Tara McCarthy, MS, RD, LDN

Clinical Nutrition Supervisor, Nutrition Center

 

 
 

In this episode, Dr. Erin Syverson describes the relationship between celiac disease and eosinophilic esophagitis. Furthermore, Dr. Syverson identifies indicators to test a patient with celiac disease for eosinophilic esophagitis. Dr. Syverson and Tara McCarthy, MS, RD, LDN also explain the nutritional challenges for patients with a dual diagnosis of celiac disease and eosinophilic esophagitis.


Learning Objectives: 

At the conclusion of this educational program, learners will be able to:

  1. Describe the relationship between celiac disease and eosinophilic esophagitis
  2. Identify indicators to test a patient with celiac disease for eosinophilic esophagitis
  3. Explain nutritional challenges for patients with a dual diagnosis of celiac disease and eosinophilic esophagitis

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician

Boston Children’s Hospital designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Social Worker

As a Jointly Accredited Organization, Boston Children’s Hospital is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Boston Children’s Hospital maintains responsibility for this course. Social workers completing this course receive 0.75 ACE CE continuing education credits.

Nurse

Boston Children’s Hospital designates this activity for 0.75 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity. 

Dietician

Boston Children’s Hospital designates this activity for 0.75 contact hours for dieticians. Dieticians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement

The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Vanessa Weisbrod: None

Janis Arnold, MSW, LICSW: None

Erin Syverson, MD: Sanofi/Regeneron medical advisory board

Tara McCarthy, MS, RD, LDN: None

Additional information

Credit Type

, , ,

Duration

Format

Topic

Expiration Date

Release Date